Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
5 hedge funds and large institutions have $962K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
103% more capital invested
Capital invested by funds: $475K → $962K (+$487K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
2.62% more ownership
Funds ownership: 3.72% → 6.34% (+2.6%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$361K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.8K |
| 3 |
Morgan Stanley
New York
|
+$610 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$46.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$18.3K |
PILL Hedge Fund Activity: Q3 2024 in Review
5 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q3 2024, worth a combined $962K — up 103% from $475K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PILL positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $361K. The largest seller was UBS Group, exiting entirely with an estimated $46.9K sold.
- 5 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q3 2024, up from 4 in Q2 2024.
- Funds reported $962K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q3 2024, up 103% quarter-over-quarter.
- 2 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q3 2024 and 1 closed out, a net change of +1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q3 2024 was Jane Street, an estimated $361K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q3 2024 was UBS Group, an estimated $46.9K sold.
Based on aggregated 13F filings for Q3 2024.